THE US Food and Drug Administration has written to 14 American companies selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer.
The products are sold without FDA approval, and failure to address violations of regulations may lead to product seizure, injunction and criminal prosecution.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Apr 17